Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

OWC Pharmaceutical Research Corp. Completes First Part of Cannabis-Based Ointment Safety Study

Saturday, June 30, 2018

OWC Pharmaceutical Research Corp a developer of cannabinoidbased therapies targeting a variety of different medical conditions and disorders yesterday announced a successful completion of the first part of its Phase I placebo controlled maximal dose...

Vyxeos™ Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

Saturday, June 30, 2018

Jazz Pharmaceuticals plc today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP issued a positive opinion recommending marketing authorisation of Vyxeos mg mg powder for concentrate for solution for i...

Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand

Friday, June 29, 2018

Novaliq GmbH a specialty pharmaceutical company with the first waterfree technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology announced that NovaTears a novel topical treatment of dry eye disease DED...

RedHill Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi

Friday, June 29, 2018

RedHill Biopharma Ltd a speciality company primarily focused on late clinicalstage development and commercialization of proprietary drugs for gastrointestinal GI diseases today announced that it has entered into a copromotion agreement with Napo Phar...

Purdue Pharma L.P. Announces Successful Completion of First-in-Human Study for Oncology Therapy Candidate Tinostamustine

Thursday, June 28, 2018

Purdue Pharma LP today announced successful completion of a firstinhuman Phase dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies for which there are no available therapies The study evaluated...

NucleoBio Concludes Preliminary Tests For New Drug to Treat Aggressive Prostate Cancer

Thursday, June 28, 2018

In the quest to develop a drug to effectively treat aggressive prostate cancer NucleoBio Inc has demonstrated efficacy for its newest product Prostreat Prostreat outperforms commercially available medications in inhibiting the growth and spread of th...

Erimos Pharmaceuticals Announces Phase I Oral Study of Terameprocol (EM-1421)

Wednesday, June 27, 2018

Erimos Pharmaceuticals LLC announced today in collaboration with Adult Brain Tumor Consortium ABTC and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins initiation of a multicenter phase I clinical study of their lead compound terameprocol E...

IsoPlexis Announces Research Collaboration with Nektar Therapeutics

Wednesday, June 27, 2018

IsoPlexis Corporation a privately held life sciences company at the forefront of singlecell analytics technology announced today its collaboration with Nektar Therapeutics The collaboration is focused on further defining the functional impact of NKT...

Roche Expands Access to the Diabetes Management Solution mySugr in the US and Canada

Tuesday, June 26, 2018

Roche today announced the signing of a partnership agreement and investment in Care Innovations a leading provider of telemedicine services to patients suffering from chronic conditions Illnesses that connect remotely with their care teams Under the...

FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

Tuesday, June 26, 2018

The US Food and Drug Administration today approved Epidiolex cannabidiol CBD oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy LennoxGastaut syndrome and Dravet syndrome in patients two years of age and...